Defoslimod is an analogue of lipopolysaccharide endotoxin-derived lipid A obtained from E. coli
]. It was developed as an immunotherapeutic agent for the treatment of cancer. Defoslimod acts as an agonist of Toll-like receptors 2 and 4 (TLR2 and TLR4) [2
We show the structure with chemical formula provided in the INN record for the compound (C52H100
N2O20P2). PubChem CID 56841121
, which claims to represent defoslimod has an extra carbon atom and two associated hydrogens (C53H102
N2O20P2). But note also that the structure reported in [1
] only has 51 carbon atoms.